Leukemia Research
Volume 29, Issue 8 , Pages 975-979 , August 2005

Idiopathic hypereosinophilic syndrome: a case evolving in B-lymphoblastic lymphoma

  • Maria Cristina Rapanotti

      Affiliations

    • Dipartimento di Medicina Interna, Facoltà di Medicina e Chirurgia, University “Tor Vergata”, Viale Oxford 81, 00133 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 06 20902259; fax: +39 06 20902270.
    • ,
  • Roberta Caruso

      Affiliations

    • Hematological Unit, Children's Hospital and Research Institute “Bambino Gesù”, Piazza S. Onofrio 4, 00165 Rome, Italy
    • ,
  • Sergio Bernardini

      Affiliations

    • Dipartimento di Medicina Interna, Facoltà di Medicina e Chirurgia, University “Tor Vergata”, Viale Oxford 81, 00133 Rome, Italy
    • ,
  • Valentina Coletti

      Affiliations

    • Hematological Unit, Children's Hospital and Research Institute “Bambino Gesù”, Piazza S. Onofrio 4, 00165 Rome, Italy
    • ,
  • Francesco Lo-Coco

      Affiliations

    • Dipartimento di Biopatologia e Diagnostica per Immagini, Facoltà di Medicina e Chirurgia, University “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy
    • ,
  • Giulio De Rossi

      Affiliations

    • Hematological Unit, Children's Hospital and Research Institute “Bambino Gesù”, Piazza S. Onofrio 4, 00165 Rome, Italy

Received 30 November 2004 ,Revised 18 January 2005 ,Accepted 18 January 2005.

References 

  1. Hardy WR, Anderson RE. The hypereosinophilic syndrome. Ann Intern Med. 1968;68:1220–1229
  2. Brito-Bapapulle F. The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol. 2003;121:203–223
  3. Bain BJ. The idiopathic hypereosinophilic syndrome and eosinophilic leukemias. Haematologica. 2004;89:133–136
  4. Miller SA, Dykes DD, Polesky HF. A single salting out procedure for extracting from human nucleated cells. Nucleic Acid Res. 1988;16:1215
  5. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-chloroform extraction. Anal Biochem. 1987;162:156–159
  6. Nizet Y, Martiat P, Vaerman J, Philippe M, Wildmann C, Staenlens J, et al. Follow-up of residual disease (MRD) in B lineage acute leukemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. Br J Haematol. 1991;79:205–210
  7. Diss TC, Peng H, Wotherspoon P, Isacsoon PG, Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol. 1993;169:291–295
  8. van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia. 1999;13:1901–1928
  9. Brugnoni D, Airo P, Rossi G, Bettinardi A, Simon HU, Garza L, et al. A case of hypereosinophilic syndrome is associated with the expansion a CD3−CD4+ T cell population able to secrete large amount of interleuchin-5. Blood. 2003;87:1416–1422
  10. Cogan E, Schandené L, Crusiaux A, Cochaux P, Velu T, Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. New Engl J Med. 1994;330:535–538
  11. Roufosse F, Schandené L, Sibille C, Willard-Gallo K, Kennes B, Efira A, et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol. 2000;109:540–548
  12. Bain BJ. An overview of translocation-related oncogenesis in the cronic myeloid leukaemias. Acta Haematol. 2002;107:57–63
  13. Malbrain MLNG, Van den Bergh H, Zachée P. Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality. Br J Haematol. 1996;92:176–183
  14. Wlodarska I, Mecucci C, Marynen P, Guo C, Fransky D, La Starza R, et al. TEL gene is involved in myelodysplastic syndrome with either the typical t(5:12) (q33; p13) or its variant t(10:12) (q24; p13). Blood. 1995;85:2848–2852
  15. Michaux JL, Mecucci C, Velloso ERP, Dierlamm J, Cries A, Louwagie A, et al. About the t(8:13)(p11; q12) clinico-pathologic entity. Blood. 1996;87:1658–1659
  16. Cools J, De Angelo D, Gotlib J, Stover E, Phil M, Legare RD, et al. A tyrosinase kinase created by fusion of the PDGFRA and FILPL1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. NEJM. 2003;348:1201–1214
  17. Gotlib J, Cools J, Malone JM, Schrier SL, Gilliland GD, Coutré SE. The FILPL1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chrinic eosinophilic leukemia: implications for diagnostic, classification, and management. Blood. 2004;103:287991
  18. Bernasconi C. Hypereosinophilia in acute lymphoblastic leukemia: an association to be rembered. Haematologica. 2001;86:893
  19. Urtasùn JA, Izquierdo AY, Barroso BR, Huerta AS. Hipereosinophilia mantenida que precede al diagnostico de una leucemia linfoblastica aguda. Med Clin. 2001;116:38–39

PII: S0145-2126(05)00056-1

doi: 10.1016/j.leukres.2005.01.010

Leukemia Research
Volume 29, Issue 8 , Pages 975-979 , August 2005

Article Tools

* Image Usage & Resolution